If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 2,203,800 shares, except that Foresite Capital Management VI, LLC ("FCM VI"), the general partner of Foresite Capital Fund VI LP ("Fund VI"), may be deemed to have sole power to vote these shares, and James B. Tananbaum ("Tananbaum"), the managing member of FCM VI, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 2,203,800 shares, except that FCM VI, the general partner of Fund VI, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM VI, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of Latigo Biotherapeutics, Inc. (the "Issuer") outstanding as of August 7, 2026, as set forth in the Issuer's Prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission ("SEC") on August 7, 2026 (the "Prospectus").


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 2,203,800 shares, all of which are directly owned by Fund VI. FCM VI, the general partner of Fund VI, may be deemed to have sole power to vote these shares, and Tananbaum, the managing member of FCM VI, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 2,203,800 shares, all of which are directly owned by Fund VI. FCM VI, the general partner of Fund VI, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM VI, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 3,562,984 shares, except that Foresite Capital Management V, LLC ("FCM V"), the general partner of Foresite Capital Fund V, L.P. ("Fund V"), may be deemed to have sole power to vote these shares, and Tananbaum, the managing member of FCM V, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 3,562,984 shares, except that FCM V, the general partner of Fund V, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM V, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 3,562,984 shares, all of which are directly owned by Fund V. FCM V, the general partner of Fund V, may be deemed to have sole power to vote these shares, and Tananbaum, the managing member of FCM V, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 3,562,984 shares, all of which are directly owned by Fund V. FCM V, the general partner of Fund V, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCM V, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 3,414,544 shares, except that Foresite Capital Opportunity Management V, LLC ("FCOM V"), the general partner of Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"), may be deemed to have sole power to vote these shares, and Tananbaum, the managing member of FCOM V, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 3,414,544 shares, except that FCOM V, the general partner of Opportunity Fund V, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCOM V, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 3,414,544 shares, all of which are directly owned by Opportunity Fund V. FCOM V, the general partner of Opportunity Fund V, may be deemed to have sole power to vote these shares, and Tananbaum, the managing member of FCOM V, may be deemed to have sole power to vote these shares. Note to Row 8: See response to row 7. Note to Row 9: 3,414,544 shares, all of which are directly owned by Opportunity Fund V. FCOM V, the general partner of Opportunity Fund V, may be deemed to have sole power to dispose of these shares, and Tananbaum, the managing member of FCOM V, may be deemed to have sole power to dispose of these shares. Note to Row 10: See response to row 9. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: 9,181,328 shares, of which 2,203,800 shares are directly owned by Fund VI, 3,562,984 shares are directly owned by Fund V and 3,414,544 shares are directly owned by Opportunity Fund V. Tananbaum is the managing member of each of FCM VI, which is the general partner of Fund VI; FCM V, which is the general partner of Fund V; and FCOM V, which is the general partner of Opportunity Fund V. Tananbaum may be deemed to have sole power to vote the shares directly owned by Fund VI, Fund V and Opportunity Fund V. Note to Row 9: 9,181,328 shares, of which 2,203,800 shares are directly owned by Fund VI, 3,562,984 shares are directly owned by Fund V and 3,414,544 shares are directly owned by Opportunity Fund V. Tananbaum is the managing member of each of FCM VI, which is the general partner of Fund VI; FCM V, which is the general partner of Fund V; and FCOM V, which is the general partner of Opportunity Fund V. Tananbaum may be deemed to have sole power to dispose of the shares directly owned by Fund VI, Fund V and Opportunity Fund V. Note to Row 13: This percentage is calculated based upon 63,238,030 shares of common stock of the Issuer outstanding as of August 7, 2026, as set forth in the Prospectus.


SCHEDULE 13D


 
Foresite Capital Fund VI LP
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member of the General Partner
Date:08/17/2026
 
Foresite Capital Management VI, LLC
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member
Date:08/17/2026
 
Foresite Capital Fund V, L.P.
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member of the General Partner
Date:08/17/2026
 
Foresite Capital Management V, LLC
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member
Date:08/17/2026
 
Foresite Capital Opportunity Fund V, L.P.
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member of the General Partner
Date:08/17/2026
 
Foresite Capital Opportunity Management V, LLC
 
Signature:/s/ James B. Tananbaum
Name/Title:James Tananbaum, Managing Member
Date:08/17/2026
 
James B. Tananbaum
 
Signature:/s/ James B. Tananbaum
Name/Title:James B. Tananbaum
Date:08/17/2026

 

Exhibit A

 

The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Latigo Biotherapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

 

Date: August 17, 2026

 

  FORESITE CAPITAL FUND VI LP
   
  By: Foresite Capital Management VI, LLC
  Its: General Partner
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  FORESITE CAPITAL MANAGEMENT VI, LLC
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  FORESITE CAPITAL FUND V, L.P.
   
  By: Foresite Capital Management V, LLC
  Its: General Partner
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  FORESITE CAPITAL MANAGEMENT V, LLC
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  FORESITE CAPITAL OPPORTUNITY FUND V, L.P.
   
  By: Foresite Capital Opportunity Management V, LLC
  Its: General Partner
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC
   
  By: /s/ James B. Tananbaum
    James B. Tananbaum
    Managing Member
   
  JAMES B. TANANBAUM
   
  /s/ James B. Tananbaum